Скачать или смотреть TRYSINTEC Fundraising Experience with G.I.L.C. club

M. Damian Billy, Founder and MP at TRYSINTECH, The Econophy Group
ABOUT PROJECT

TRISYNTEC is redesigning the functionality and purpose of a predictive artificial intelligence (AI) with a data-driven, digitally focused NMMI pulmonary disease diagnostic technology in collaboration with a noninvasive, de novo wearable therapeutic medical device having derivative respiratory disease applications for TB, COPD, and Sleepapnea. Embedded sensors will transmit patient experience data to an AI epidemiology platform.

Through Clinexel Life Sciences, a global strategic partner, we gain a tandem relationship with the Indian government’s Biotechnology Industry Research Assistance Council (BIRAC) to begin an accelerated adaptive Phase III clinical trial for regulatory approval toward commercialization of three products. Our innovative, world-class pulmonary disease pipeline will evolve to five (5) products for the purpose of mitigating pulmonary disease prevalence.

Prior clinical trials have demonstrated a 40% breathing enhancement for device users. Worn twice daily, the at-home therapy is battery operated.

https://gilc.club/projects/1044